earnings
confidence high
sentiment negative
materiality 0.75
Cross Country Q2 revenue down 37% YoY to $339.8M; net loss of $16.0M
CROSS COUNTRY HEALTHCARE INC
2024-Q2 EPS reported
-$0.39
revenue$718,945,000
- Revenue $339.8M, down 37% YoY and 10% sequentially; gross margin 20.8% (-200 bps YoY).
- Net loss attributable to common $16.0M vs net income in Q2 2023; diluted EPS ($0.47).
- Adjusted EBITDA $14.2M, margin 4.2% (-400 bps YoY); adjusted EPS $0.10 vs ($0.59) a year ago.
- Cash from operations $82.4M, up 1,271% sequentially; no guidance update provided.